C-286Outside the Order of PrecedencePrivate Member’s Bill
An act to amend the Controlled Drugs and Substances Act and the Food and Drugs Act
Short title: An act to amend the Controlled Drugs and Substances Act and the Food and Drugs Act
Sponsor:
Corey Tochor, Member of Parliament (Saskatoon East)
Proposed changes
This enactment amends the Controlled Drugs and Substances Act and the Food and Drugs Act to allow psilocin and psilocybin to be used for medical treatment in accordance with the Narcotic Control Regulations . It also provides for the automatic approval of requests for priority review for certain new drugs.
The path to law
Every bill has to clear each step, in both chambers. Tap a step's name to learn what it means.
· House of Commons
Completed.
June 16, 2026
· House of CommonsNext up
Current step.
· House of Commons
Not reached yet.
Not reached yet
· House of Commons
Not reached yet.
Not reached yet
· Senate
Not reached yet.
Not reached yet
· Senate
Not reached yet.
Not reached yet
· Senate
Not reached yet.
Not reached yet
· Senate
Not reached yet.
Not reached yet
· Governor General
Not reached yet.
Not reached yet
Who's lobbying on it
2 organizations named this bill in their lobbying registration or in
3 reported meetings. Their own words are quoted.
Optimi Health Corp2 meetings · registered to lobby on it · latest Oct 22, 2026
“C-286 An act to amend the Controlled Drugs and Substances Act and the Good and Drugs Act. Discuss proposed amendments related to the regulation of psilocybin and psilocin…”
Optimi Health Corp1 meeting · registered to lobby on it · latest Oct 22, 2026
“C-286 An act to amend the Controlled Drugs and Substances Act and the Good and Drugs Act. Discuss proposed amendments related to the regulation of psilocybin and psilocin…”
From the Commissioner of Lobbying. A bill is listed when the lobbyist's description makes clear it means this bill, not one with the same number from another Parliament.